Brief: Starton Therapeutics Inc. And Healthwell Acquisition Corp. I To Combine And Create Publicly Traded Leader In Proprietary Continuous Delivery Technology For Cancer Treatments

Healthwell Acquisition I

27/04/2023 12:11

April 27 (Reuters) - Healthwell Acquisition Corp I
 HWEL.O :
    * STARTON THERAPEUTICS INC. AND HEALTHWELL ACQUISITION CORP.
I TO
COMBINE AND CREATE PUBLICLY TRADED LEADER IN PROPRIETARY
CONTINUOUS DELIVERY TECHNOLOGY FOR CANCER TREATMENTS
    * HEALTHWELL ACQUISITION CORP I - COMBINED CO TO HAVE
ESTIMATED
POST-DEAL ENTERPRISE VALUE OF $339 MILLION & EQUITY VALUE OF
$374 MILLION, ASSUMING SHARE PRICE AT CLOSING OF $10.15
    * HEALTHWELL ACQUISITION CORP I - POST COMPLETION OF
BUSINESS
COMBINATION, ANTICIPATED DURING H2 2023, SHARES OF STARTON ARE
EXPECTED TO TRADE ON NASDAQ
    * HEALTHWELL ACQUISITION CORP I - AFTER CONSUMMATION OF
TRANSACTION, COMMON STOCK AND WARRANTS OF PUBCO ARE EXPECTED TO
BE LISTED ON NASDAQ

Source text for Eikon:  ID:nBw30prRGa 
Further company coverage:  HWEL.O 

 (Reporting by Siddarth S)
 ((Siddarth.s@thomsonreuters.com;))